ArticleExperimental hematology & oncology2024

Vertical targeting of the PI3K/AKT pathway at multiple points is synergistic and effective for non-Hodgkin lymphoma.

Kristyna Kupcova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.